Your session is about to expire
← Back to Search
Behavioral Intervention
CALM Therapy for Primary Brain Tumor Distress
N/A
Waitlist Available
Led By Terri S Armstrong, C.R.N.P.
Research Sponsored by National Cancer Institute (NCI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 and 6 months compared to baseline
Awards & highlights
Study Summary
This trial is testing whether the CALM therapy can help people with a CNST suffering from distress. English-speaking adults with a CNST may be eligible. The study will be done by smartphone, computer, or tablet.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 and 6 months compared to baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 and 6 months compared to baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
feasibility of implementing CALM remotely
reduction of anxiety score using the Death and Dying Distress Scale (DADDS)
reduction of depressive symptoms using the PROMIS-Depression scale in PCNST participants
Trial Design
1Treatment groups
Experimental Treatment
Group I: Arm 1Experimental Treatment1 Intervention
Remote CALM therapy for participants with newly or recurrent PCNST
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)Lead Sponsor
13,708 Previous Clinical Trials
40,932,716 Total Patients Enrolled
82 Trials studying Depression
66,110 Patients Enrolled for Depression
Terri S Armstrong, C.R.N.P.Principal InvestigatorNational Cancer Institute (NCI)
5 Previous Clinical Trials
1,588 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have confirmed brain or spinal cord cancer and are currently receiving standard treatment or taking part in a research study.
Research Study Groups:
This trial has the following groups:- Group 1: Arm 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there opportunities for new participants to enter this clinical research?
"Data hosted on clinicaltrials.gov indicates that this medical trial, which was first made available on August 11th 2021, is not currently enrolling patients. However, there are presently 1529 different studies seeking participants in the United States of America."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger